Opportunities Preloader

Please Wait.....

Report

Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Report I 2023-05-29 I 143 Pages I IMARC Group

The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.

Liquid biopsy is a non-invasive alternative to surgical biopsies enabling doctors to obtain information about a tumor through a blood sample and plan the treatment accordingly. It can reflect changes in tumor gene expression profile and offer a robust base for individualized therapy. It assists in the early diagnosis screening, tumor heterogeneity and drug resistance. Besides this, it also detects epidermal growth factor receptor (EGFR) gene mutations, which occur among patients with non-small cell lung cancer (NSCLC).

Liquid Biopsy Market Trends:
Due to sedentary lifestyles and rising tobacco consumption, there is a surge in the number of cancer patients across the globe. This, along with the growing awareness among individuals about advanced minimally invasive (MI) procedures in cancer diagnostics, represents one of the key factors driving the market. Moreover, governing authorities of several countries are financing research and development (R&D) activities to encourage the introduction of advanced cancer solutions. These authorities are also considerable investing in the development of the healthcare industry, which is offering lucrative growth opportunities to industry players. Apart from this, key market players are focusing on product launches to develop personalized medicine worldwide. They are also integrating technological advancements in liquid biopsy to offer better procedure workflow and output. This, coupled with the rising adoption of blood-based biopsy tests for early tumor detection, is positively influencing the market. Additionally, the increasing usage of exosomes for clinical diagnosis in oncology to provide high accuracy and reduced procedural time is catalyzing the demand for liquid biopsy. Growth-inducing factors projected to impel the market growth are rapid development in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) based technology.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid biopsy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, circulating biomarker, cancer type and end user.

Breakup by Product and Service:

Kits and Reagents
Platforms and Instruments
Services

Breakup by Circulating Biomarker:

Circulating Tumor Cells
Extracellular Vesicles
Circulating Tumor DNA
Others

Breakup by Cancer Type:

Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Others

Breakup by End User:

Hospitals and Laboratories
Academic and Research Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global liquid biopsy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global liquid biopsy market?
What are the key regional markets?
What is the breakup of the market based on the product and service?
What is the breakup of the market based on the circulating biomarker?
What is the breakup of the market based on the cancer type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global liquid biopsy market and who are the key players?
What is the degree of competition in the industry?

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Liquid Biopsy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Service
6.1 Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Platforms and Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Circulating Biomarker
7.1 Circulating Tumor Cells
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Extracellular Vesicles
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Circulating Tumor DNA
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Cancer Type
8.1 Lung Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Breast Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Liver Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Research Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 ANGLE plc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Biocept Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.3 Bio-Rad Laboratories Inc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Epigenomics AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Exact Sciences Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F.Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Guardant Health Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Illumina Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 MDxHealth SA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Menarini Silicon Biosystems
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 QIAGEN N.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis

Figure 1: Global: Liquid Biopsy Market: Major Drivers and Challenges
Figure 2: Global: Liquid Biopsy Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Liquid Biopsy Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Liquid Biopsy Market: Breakup by Product and Service (in %), 2022
Figure 5: Global: Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2022
Figure 6: Global: Liquid Biopsy Market: Breakup by Cancer Type (in %), 2022
Figure 7: Global: Liquid Biopsy Market: Breakup by End User (in %), 2022
Figure 8: Global: Liquid Biopsy Market: Breakup by Region (in %), 2022
Figure 9: Global: Liquid Biopsy (Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Liquid Biopsy (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Liquid Biopsy (Platforms and Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Liquid Biopsy (Platforms and Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Liquid Biopsy (Circulating Tumor Cells) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Liquid Biopsy (Circulating Tumor Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Liquid Biopsy (Extracellular Vesicles) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Liquid Biopsy (Extracellular Vesicles) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Liquid Biopsy (Circulating Tumor DNA) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Liquid Biopsy (Circulating Tumor DNA) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Liquid Biopsy (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Liquid Biopsy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Liquid Biopsy (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Liquid Biopsy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Liquid Biopsy (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Liquid Biopsy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Liquid Biopsy (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Liquid Biopsy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Liquid Biopsy (Liver Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Liquid Biopsy (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Liquid Biopsy (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Liquid Biopsy (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Liquid Biopsy (Hospitals and Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Liquid Biopsy (Hospitals and Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Liquid Biopsy (Academic and Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Liquid Biopsy (Academic and Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: North America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: North America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United States: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United States: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Canada: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Canada: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Asia-Pacific: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Asia-Pacific: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: China: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: China: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Japan: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Japan: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: India: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: India: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: South Korea: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: South Korea: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Australia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Australia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Indonesia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Indonesia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Europe: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Europe: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Germany: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Germany: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: France: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: France: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: United Kingdom: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: United Kingdom: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Italy: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Italy: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Spain: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Spain: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Russia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Russia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Latin America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Latin America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Brazil: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Brazil: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Mexico: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Mexico: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Middle East and Africa: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Middle East and Africa: Liquid Biopsy Market: Breakup by Country (in %), 2022
Figure 89: Middle East and Africa: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Global: Liquid Biopsy Industry: SWOT Analysis
Figure 91: Global: Liquid Biopsy Industry: Value Chain Analysis
Figure 92: Global: Liquid Biopsy Industry: Porter's Five Forces Analysis

Table 1: Global: Liquid Biopsy Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Liquid Biopsy Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
Table 3: Global: Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2023-2028
Table 4: Global: Liquid Biopsy Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
Table 5: Global: Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Liquid Biopsy Market: Competitive Structure
Table 8: Global: Liquid Biopsy Market: Key Players

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $2499.00
  • $3499.00
  • $4499.00
  • ADD TO BASKET
  • BUY NOW